Assignee
CYBIN IRL LTD
IE·9 granted patents·17 pending applications·58 citations·filing 2021–2025
Top patents by PatentIndex Score
26 records- 0198US11242318B2Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2021·Granted Feb 8, 2022·38 cites·53 claims
- 0297US11724985B2Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2021·Granted Aug 15, 2023·7 cites·12 claims
- 0396US11834410B2Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2023·Granted Dec 5, 2023·5 cites·10 claims
- 0496US11746088B2Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2022·Granted Sep 5, 2023·5 cites·11 claims
- 0595US11958807B2Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2023·Granted Apr 16, 2024·3 cites·9 claims
- 0691US12291499B2Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2024·Granted May 6, 2025·0 cites·17 claims
- 0791US2025011282A1Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2024·Application pending·0 cites
- 0885US12110272B2Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2023·Granted Oct 8, 2024·0 cites·18 claims
- 0983US2025230128A1Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2025·Application pending·0 cites
- 1082US2023126298A1Deuyerated tryptamine derivative formulations and methods of useCYBIN IRL LTD·Filed 2022·Application pending·0 cites
- 1179US12240813B2Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2021·Granted Mar 4, 2025·0 cites·20 claims
- 1277US2025154101A1Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2025·Application pending·0 cites
- 1366US2024425451A1Therapeutic phenethylamine compositions and methods of useCYBIN IRL LTD·Filed 2024·Application pending·0 cites
- 1465US2025082607A2Methods of treating disorders with a psilocybin analogCYBIN IRL LTD·Filed 2024·Application pending·0 cites
- 1562US2025360148A1Solid dispersions of psilocybinCYBIN IRL LTD·Filed 2023·Application pending·0 cites
- 1661US12122741B2Therapeutic phenethylamine compositions and methods of useCYBIN IRL LTD·Filed 2021·Granted Oct 22, 2024·0 cites·13 claims
- 1760US2025213527A1Formulations of psilocybin analogs and methods of useCYBIN IRL LTD·Filed 2022·Application pending·0 cites
- 1859US2024174607A1Psilocybin analogs, salts, compositions, and methods of useCYBIN IRL LTD·Filed 2022·Application pending·0 cites
- 1958US2024261306A1Formulations of psilocybinCYBIN IRL LTD·Filed 2022·Application pending·0 cites
- 2058US2025205198A1Methods for delivery of psychedelic medications by inhalation and systems for performing the methodsCYBIN IRL LTD·Filed 2023·Application pending·0 cites
- 2155US2025236589A1Therapeutic phenethylamine compositions and methods of useCYBIN IRL LTD·Filed 2023·Application pending·0 cites
- 2253US2025145566A1Phenethylamine derivatives, compositions, and methods of useCYBIN IRL LTD·Filed 2023·Application pending·0 cites
- 2352US2024366655A1Combination drug therapiesCYBIN IRL LTD·Filed 2022·Application pending·0 cites
- 2452US2023355583A1Methods for delivery of psychedelic medications by inhalation and systems for performing the methodsCYBIN IRL LTD·Filed 2021·Application pending·0 cites
- 2550US2025051279A1Tryptamine compositions and methodsCYBIN IRL LTD·Filed 2023·Application pending·0 cites
- 2637US2024293082A1Integrated data collection devices for use in various therapeutic and wellness applicationsCYBIN IRL LTD·Filed 2022·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →